Oxaliplatin, 5-fluorouracil and leucovorin (modified FOLFOX-6) as first-line chemotherapy for advanced gastric cancer patients with poor performance status

This study was designed to retrospectively evaluate the efficacy and safety of modified FOLFOX-6 regimen in advanced gastric cancer (AGC) patients with poor performance status (PS). From January 2005 to August 2010, 23 AGC patients with poor PS who received mFOLFOX-6 as first-line chemotherapy were...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: KIM, HYEONG SU, KIM, JUNG HAN, KIM, HEE JUN, JANG, HYUN JOO, KIM, JIN BAE, KIM, JI WON, JUNG, SO YOUNG, KIM, BYUNG CHUN, YANG, DAE HYUN, PARK, SOAH, KIM, KEONG JU, LEE, SOON IL, ZANG, DAE YOUNG
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: D.A. Spandidos 2012
Onderwerpen:
Articles
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3362383/
https://ncbi.nlm.nih.gov/pubmed/22740925
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2011.496
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items